Enhanced polo-like kinase 1 expression in myelodysplastic syndromes.
Conclusion: PLK1 is upregulated in MDS patients; however, its role in the pathophysiology of MDS is unclear. Gene upregulation in cases with pharmacotherapeutic resistance warrants further investigation.
PMID: 31309087 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Genetics | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Study